Cargando…

Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients

Detalles Bibliográficos
Autores principales:	Bertrand, Dominique, Hanoy, Mélanie, Edet, Stéphane, Lemée, Veronique, Hamzaoui, Mouad, Laurent, Charlotte, Ludivine, Lebourg, Etienne, Isabelle, Lemoine, Mathilde, Nezam, Dorian, Candon, Sophie, Plantier, Jean-Christophe, Le Roy, Frank, Guerrot, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344605/ https://www.ncbi.nlm.nih.gov/pubmed/34471524 http://dx.doi.org/10.1093/ckj/sfab100

Ejemplares similares

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2021)

Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2022)

SARS-CoV-2–specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19
por: Bertrand, Dominique, et al.
Publicado: (2021)

Efficacy of anti–SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2022)

Haemodialysis catheterization via type II persistent left superior vena cava
por: Guerrot, Dominique, et al.
Publicado: (2008)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in France
por: Bertrand, Dominique, et al.
Publicado: (2023)

Ipilimumab-induced renal granulomatous arteritis: a case report
por: Lemoine, Mathilde, et al.
Publicado: (2019)

von Brünn Nests Hyperplasia as a Cause of Ureteral Stenosis After Kidney Transplantation
por: Hamzaoui, Mouad, et al.
Publicado: (2016)

5/6 nephrectomy induces different renal, cardiac and vascular consequences in 129/Sv and C57BL/6JRj mice
por: Hamzaoui, Mouad, et al.
Publicado: (2020)

Humoral response after BNT162b2 mRNA COVID-19 vaccination in patients on haemodialysis depends on immune status
por: Ducloux, Didier, et al.
Publicado: (2021)

Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis
por: Dekervel, Marine, et al.
Publicado: (2021)

Monitoring of hemodialysis quality-of-care indicators: why is it important?
por: Grangé, Steven, et al.
Publicado: (2013)

Campylobacter fetus bacteremia complicated by multiple splenic abscesses and multivisceral signs in a renal transplant recipient: a case report and review of the literature
por: Coustillères, François, et al.
Publicado: (2022)

BNT162b2 vaccine uptake and effectiveness in UK healthcare workers – a single centre cohort study
por: Azamgarhi, Tariq, et al.
Publicado: (2021)

Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres
por: Arenas Jimenez, María Dolores, et al.
Publicado: (2022)

Low-Volume Home Haemodialysis and In-Centre Haemodialysis: Comparison of Dialysis Adequacy in Obese Individuals
por: Alalwan, Adel A, et al.
Publicado: (2023)

Patient satisfaction with in-centre haemodialysis care: an international survey
por: Palmer, Suetonia C, et al.
Publicado: (2014)

Tuberculosis in haemodialysis patients: A single centre experience
por: Rao, T. Manmadha, et al.
Publicado: (2013)

Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome
por: Hamzaoui, Mouad, et al.
Publicado: (2021)

Survey of food offered to United Kingdom haemodialysis patients attending for dialysis sessions in main dialysis centres and satellite units and international comparison
por: Davenport, Andrew
Publicado: (2023)

Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas
por: Candon, Sophie, et al.
Publicado: (2021)

A prospective study of fatigue trajectories among in‐centre haemodialysis patients
por: Picariello, Federica, et al.
Publicado: (2019)

Ethical challenges in managing unvaccinated patients receiving chronic in-centre haemodialysis
por: Alfano, Gaetano, et al.
Publicado: (2021)

Risk assessment of failure during transitioning from in-centre to home haemodialysis
por: Haroon, Sabrina-Wong-Peixin, et al.
Publicado: (2022)

Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
por: Shmueli, Einat S., et al.
Publicado: (2021)

Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population
por: Malissen, Nausicaa, et al.
Publicado: (2021)

Stability testing of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine: a translational study in UK vaccination centres
por: Kudsiova, Laila, et al.
Publicado: (2021)

The impact of in-centre haemodialysis treatment on the everyday life of older adults with end-stage kidney disease: a qualitative study
por: Moreels, Timothy, et al.
Publicado: (2023)

Association of anti-HCV sero-prevalence with blood transfusion and practice of haemodialysis from multiple centres in patients on maintenance haemodialysis
por: Amjad, Umbreen, et al.
Publicado: (2020)

Protective antibody response to mRNA-1273 and BNT162b2 vaccines in patients on maintenance haemodialysis: a prospective cohort study
por: Dimitrov, Yves, et al.
Publicado: (2022)

Epidemiology of haemodialysis catheter complications: a survey of 865 dialysis patients from 14 haemodialysis centres in Henan province in China
por: Wang, Kai, et al.
Publicado: (2015)

Rationale and design for SHAREHD: a quality improvement collaborative to scale up Shared Haemodialysis Care for patients on centre based haemodialysis
por: Fotheringham, James, et al.
Publicado: (2017)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

A 4-month programme of in-centre nocturnal haemodialysis was associated with improvements in patient outcomes
por: Graham-Brown, Matthew P.M., et al.
Publicado: (2015)

Integrating peritoneal and home haemodialysis: a nurse’s perspective from a single centre
por: Rhodes, Carol, et al.
Publicado: (2011)

Vaccination against COVID-19 in a haemodialysis centre: what is the risk of bleeding complications?
por: Giot, Matthieu, et al.
Publicado: (2021)

Clinical Profile and Outcome of Haemodialysis in Patients With COVID-19 – A Single Centre Experience
por: Vardhan, Harsh, et al.
Publicado: (2021)

Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 Years
por: Lemoine, Mathilde, et al.
Publicado: (2019)

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
por: Becker, Matthias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e5qh8m0fqojv5n451vbtag9769